ArticleFrontiers in immunology2025
Case report: Plasma exchange as a therapy for Miller-Fisher syndrome.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is a report of an anti-GQ1b antibody-negative case of Miller-Fisher syndrome, presenting with diplopia and gait disturbance 3 days after catching a cold, accompanied by dizziness and headache, pain in the eyeballs and orbits, superficial sensory loss, ptosis, eye movements fixed in the middle of eyes, and limb weakness. Physical examination suggested that the patient had eye movements fixed in the middle of eyes, limb muscle strength was reduced, and the bilateral finger-to-nose and heel-knee-shin tests were clumsy and dysmetric. Assistant examinations showed albumin-cytologic dissociation in cerebrospinal fluid, incomplete bilateral facial nerve lesions, and negative anti-GQ1b antibody. After being treated with plasma exchange, the patient experienced slight improvement in eye adduction when she was discharged from the hospital and her diplopia and limb weakness were significantly improved. She could walk on her own without dizziness or headache and the pain in her eyeballs and orbits was completely relieved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.